HURRICANE MILTON: BLOOD AND PLATELET DONATIONS NEEDED TO MAINTAIN BLOOD SUPPLY Bethesda, Md. – As Hurricane Milton is expected to make landfall soon, the AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism has activated and is monitoring the blood supply and preparing for potential disruptions in blood

The American Red Cross is sounding the alarm that the United States’ blood supply has fallen by nearly 25% since early August, to what it describes as “critically low levels.” READ MORE

June 12, 2019 Blood Donation: Millennials Needed If more millennials step up to give, they can fill the gap left by aging baby boomers. See why their donations may move the needle. Blood Donation: Millennials Needed | Abbott Newsroom

Jefferson Parish President Cynthia Lee Sheng hosted a webinar with the US Surgeon General for faith leaders in Jefferson Parish about The Fight Is In Us, a national coalition that helps people who have recently recovered from COVID-19 become heroes by donating blood plasma.

America’s Blood Centers (ABC) has distributed a national news release regarding the role that community blood centers are playing in the collection of CCP as part of the nation’s response efforts to COVID-19. Additionally, ABC, AABB, and the American Red Cross have developed a joint statement on CCP to align

The AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism issued the following statement regarding blood donation during the COVID-19 pandemic. READ MORE

“We Need People to Start Turning Out in Force to Give Blood” FDA Urging People to Donate Blood as Coronavirus Fears Intensify (Washington, DC – March 12, 2020) – “We need people to start turning out in force to give blood.” That urgent call-to-action coming from Peter Marks, M.D., Ph.D.,

The International Plasma and Fractionation Association (IPFA) is pleased to announce the fourth IPFA Asia Workshop on Plasma Quality and Supply. This workshop will build on the success of the meetings held in Taiwan in 2016, Indonesia in 2017 and Malaysia in 2018, which highlighted the importance of this topic

Immucor PreciseType™ HEA Test Becomes the First-Ever FDA-Approved Diagnostic for Molecular Typing of Donor and Recipient Red Blood Cells for Blood Transfusions Addresses critical unmet needs in blood banking and transfusion medicine – a fast, FDA-approved way to generate critical genetic matching information necessary to: Prevent alloimmunization and reduce risk